Suppression of CCL2/MCP-1 and CCL5/RANTES expression by nociceptin in human monocytes

Journal of NeuroImmune Pharmacology

Volumn 3, Issue 2, 2008, Pages 75-82

  Kaminsky, David E ^a   Rogers, Thomas J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemokine; Monocyte; Nociceptin; ORL1

Indexed keywords

CCL2 PROTEIN, HUMAN; CCL5 PROTEIN, HUMAN; CD14 ANTIGEN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NOCICEPTIN; NOCICEPTIN RECEPTOR; OPIATE PEPTIDE; OPIATE RECEPTOR; RANTES;

ADULT; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL STRAIN U937; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; METABOLISM; MONOCYTE; NEUTROPHIL CHEMOTAXIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ANTIGENS, CD14; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL5; CHEMOTAXIS, LEUKOCYTE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MONOCYTES; OPIOID PEPTIDES; RECEPTORS, OPIOID; RNA, MESSENGER; U937 CELLS;

EID: 43449083200     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-007-9086-y     Document Type: Article

References (47)

1. Anders HJ, Frink M, Linde Y, Banas B, Wornle M, Cohen CD, Vielhauer V, Nelson PJ, Grone HJ, Schlondorff D (2003) CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol 170:5658-5666
2. Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M, Grandy DK (1994) Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett 347:284-288
3. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA (1994) Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 91:3652-3656
4. Civelli O (2005) GPCR deorphanizations: the novel, the known and the unexpected transmitters. Trends Pharmacol Sci 26:15-19
5. Comerford I, Nibbs RJ (2005) Post-translational control of chemokines: a role for decoy receptors? Immunol Lett 96:163-174
6. Danek A, O'Dorisio MS, O'Dorisio TM, George JM (1983) Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes. J Immunol 131:1173-1177
7. Delgado M, Pozo D, Ganea D (2004) The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 56:249-290
8. Dumoulin FL, Nischalke HD, Leifeld L, von dem Bussche A, Rockstroh JK, Sauerbruch T, Spengler U (2000) Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real time PCR using multi-specific standards. J Immunol Methods 241:109-119
9. El-Hage N, Gurwell JA, Singh IN, Knapp PE, Nath A, Hauser KF (2005) Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia 50:91-106
10. El-Hage N, Wu G, Wang J, Ambati J, Knapp PE, Reed JL, Bruce-Keller AJ, Hauser KF (2006) HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia 53:132-146
11. Fiset ME, Gilbert C, Poubelle PE, Pouliot M (2003) Human neutrophils as a source of nociceptin: a novel link between pain and inflammation. Biochemistry 42:10498-10505
12. Fukuda K, Kato S, Mori K, Nishi M, Takeshima H, Iwabe N, Miyata T, Houtani T, Sugimoto T (1994) cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett 343:42-46
13. Guerrero JM, Prieto JC, Elorza FL, Ramirez R, Goberna R (1981) Interaction of vasoactive intestinal peptide with human blood mononuclear cells. Mol Cell Endocrinol 21:151-160
14. Hantos MB, Szalay F, Lakatos PL, Hegedus D, Firneisz G, Reiczigel J, Torok T, Tekes K (2002) Elevated plasma nociceptin level in patients with Wilson disease. Brain Res Bull 58:311-313
15. Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1:727-730
16. Horvath A, Folhoffer A, Lakatos PL, Halosz J, Illyes G, Schaff Z, Hantos MB, Tekes K, Szalay F (2004) Rising plasma nociceptin level during development of HCC: a case report. World J Gastroenterol 10:152-154
17. Klein TW, Newton CA, Nakachi N, Friedman H (2000) Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection. J Immunol 164:6461-6466
18. Kurihara T, Warr G, Loy J, Bravo R (1997) Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186:1757-1762
19. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, Maeda N (1997) Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci USA 94:12053-12058
20. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B (1996) Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. J Immunol 156:322-327
21. Mahajan SD, Schwartz SA, Aalinkeel R, Chawda RP, Sykes DE, Nair MP (2005) Morphine modulates chemokine gene regulation in normal human astrocytes. Clin Immunol 115:323-332
22. Mahajan SD, Schwartz SA, Shanahan TC, Chawda RP, Nair MP (2002) Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor. J Immunol 169:3589-3599
23. Mandyam CD, Thakker DR, Christensen JL, Standifer KM (2002) Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk. J Pharmacol Exp Ther 302:502-509
24. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I, Overall CM (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276:43503-43508
25. McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM (2000) Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289:1202-1206
26. McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM (2002) Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100:1160-1167
27. Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC (1994) ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 341:33-38
28. Nagase H, Woessner JF Jr. (1999) Matrix metalloproteinases. J Biol Chem 274:21491-21494
29. Ottaway CA, Bernaerts C, Chan B, Greenberg GR (1983) Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells. Can J Physiol Pharmacol 61:664-671
30. Pampusch MS, Serie JR, Osinski MA, Seybold VS, Murtaugh MP, Brown DR (2000) Expression of nociceptin/OFQ receptor and prepro-nociceptin/OFQ in lymphoid tissues. Peptides 21:1865-1870
31. Peluso J, Gaveriaux-Ruff C, Matthes HW, Filliol D, Kieffer BL (2001) Orphanin FQ/nociceptin binds to functionally coupled ORL1 receptors on human immune cell lines and alters peripheral blood mononuclear cell proliferation. Brain Res Bull 54:655-660
32. Peluso J, LaForge KS, Matthes HW, Kreek MJ, Kieffer BL, Gaveriaux-Ruff C (1998) Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells. J Neuroimmunol 81:184-192
33. Proost P, Struyf S, Couvreur M, Lenaerts JP, Conings R, Menten P, Verhaert P, Wuyts A, Van Damme J (1998) Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor. J Immunol 160:4034-4041
34. Rogers TJ, Peterson PK (2003) Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol 24:116-121
35. Sarada B, Thiele D, Dang T, Lee J, Safavia A, Hersh LB, Cottam GL (1998) Anti-CD3 activation of human CD4+ T cells increases expression of the intracellular beta-endorphin endopeptidase (IDE/gamma-EpGE). J Neuroimmunol 85:59-68
36. Serhan CN, Fierro IM, Chiang N, Pouliot M (2001) Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4. J Immunol 166:3650-3654
37. Szalay F, Hantos MB, Horvath A, Lakatos PL, Folhoffer A, Dunkel K, Hegedus D, Tekes K (2004) Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma. World J Gastroenterol 10:42-45
38. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, Van Damme J, Oppenheim JJ (1995) Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 95:1370-1376
39. Thiele DL, Sarada B, Dang T, Safavi A, Hersh LB, Cottam GL (1998) Regulated expression of an endopeptidase that hydrolyses beta-endorphin during differentiation of macrophages and T cells. Adv Exp Med Biol 437:291-300
40. Trombella S, Vergura R, Falzarano S, Guerrini R, Calo G, Spisani S (2005) Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation. Peptides 26:1497-1502
41. Ueda H, Yamaguchi T, Tokuyama S, Inoue M, Nishi M, Takeshima H (1997) Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci Lett 237:136-138
42. Valente AJ, Graves DT, Vialle-Valentin CE, Delgado R, Schwartz CJ (1988) Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 27:4162-4168
43. Waits PS, Purcell WM, Fulford AJ, McLeod JD (2004) Nociceptin/orphanin FQ modulates human T cell function in vitro. J Neuroimmunol 149:110-120
44. Wang JB, Johnson PS, Imai Y, Persico AM, Ozenberger BA, Eppler CM, Uhl GR (1994) cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett 348:75-79
45. Wetzel MA, Steele AD, Eisenstein TK, Adler MW, Henderson EE, Rogers TJ (2000) Mu-opioid induction of monocyte chemoattractant protein-1, RANTES, and IFN-gamma-inducible protein-10 expression in human peripheral blood mononuclear cells. J Immunol 165:6519-6524
46. Wiik P, Opstad PK, Boyum A (1985) Binding of vasoactive intestinal polypeptide (VIP) by human blood monocytes: demonstration of specific binding sites. Regul Pept 12:145-153
47. Zhao H, Wu GC, Cao XD (2002) Immunomodulatory activity of orphanin FQ/nociceptin on traumatic rats. Acta Pharmacol Sin 23:343-348